[Phenoxybenzamine in prostatic pathology. 300 cases (author's transl)].
The authors have used alpha-blockers in the everyday treatment of prostatic symptoms for the past four years. The results are good and would appear to be more effective than the majority of other treatments. Efficacy is remarkable in dysuria and acute urinary retention. The authors report their experience based upon 300 cases. This alpha-blocker therapy using phenoxybenzamine makes it possible to delay operation and to avoid it in certain cases. In particular, it facilitates the pre- and post-operative phases. Marketing of this drug in France should be encouraged.
D000208:Acute Disease; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D010919:Placebos; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000601:surgery; D014555:Urination Disorders / Q000188:drug therapy / Q000209:etiology
D000317:Adrenergic alpha-Antagonists; D010919:Placebos; D010643:Phenoxybenzamine
La phénoxybenzamine en pathologie prostatique. A propos de 300 observations.